pindolol has been researched along with carteolol in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (77.78) | 18.7374 |
| 1990's | 1 (5.56) | 18.2507 |
| 2000's | 3 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carrupt, PA; el Tayar, N; Testa, B; Van de Waterbeemd, H | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Iijima, T; Narimatsu, A; Satoh, K; Taira, N; Yanagisawa, T | 1 |
| Beudin, P; Ducher, JL; Gibert, J; Kantelip, JP; Lauxerois, M; Pechadre, JC; Sabot, C; Trolese, JF | 1 |
| Lohmöller, G; Middeke, M; Mrowka, C; Pötzl, C; Renner, W; Zoller, W | 1 |
| Hosaka, T; Isohisa, I; Koyama, T; Maezawa, H; Namba, K; Shima, K; Yamashita, K | 1 |
| Koike, K; Nakagoshi, A; Takayanagi, I | 1 |
| Amano, H; Kubo, T; Kuwahara, M; Misu, Y | 1 |
| Schnarr, KD | 1 |
| Suzuki, K; Toyama, S | 1 |
| Schuppan, U; Simon, H | 1 |
| Viehmann, P | 1 |
| O'Hara, N; Ono, H | 1 |
| Lorenz, D | 1 |
| Werning, C | 1 |
| Klaus, W; Picke, D; Rösen, R; Rump, AF | 1 |
| Horinouchi, T; Koike, K | 1 |
1 review(s) available for pindolol and carteolol
| Article | Year |
|---|---|
Modeling of beta-adrenoceptors based on molecular electrostatic potential studies of agonists and antagonists.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Models, Molecular; Receptors, Adrenergic, beta; Structure-Activity Relationship | 1988 |
5 trial(s) available for pindolol and carteolol
| Article | Year |
|---|---|
[Central effects of five beta-adrenergic receptor blockers in healthy volunteers: a quantitative EEG study].
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Brain; Carteolol; Electroencephalography; Humans; Male; Metoprolol; Monitoring, Physiologic; Pindolol; Sotalol | 1989 |
[Clinical significance of intrinsic sympathomimetic activity of the beta blocker carteolol. II: Comparative studies of carteolol and pindolol in patients with bradycardia].
Topics: Adult; Aged; Aged, 80 and over; Bradycardia; Carteolol; Clinical Trials as Topic; Electrocardiography; Female; Heart; Heart Rate; Humans; Male; Middle Aged; Pindolol; Propanolamines; Sympathetic Nervous System | 1989 |
The treatment of angina pectoris with the new beta-receptor blocker carteolol. Results of a controlled trial in comparison with pindolol.
Topics: Adult; Aging; Angina Pectoris; Carteolol; Clinical Trials as Topic; Electrocardiography; Female; Humans; Male; Middle Aged; Pindolol; Propanolamines; Radiography; Sex Factors | 1983 |
[Clinical experiences with carteolol in patients with essential hypertension].
Topics: Adult; Aged; Blood Pressure; Carteolol; Clinical Trials as Topic; Double-Blind Method; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Pindolol; Propanolamines; Renin; Time Factors | 1983 |
[Carteolol in essential hypertension. Dose range study and controlled open trial in comparison with pindolol].
Topics: Adult; Carteolol; Female; Humans; Hypertension; Male; Middle Aged; Pindolol; Propanolamines | 1983 |
12 other study(ies) available for pindolol and carteolol
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Effects on atrio-ventricular conduction of propranolol, pindolol and carteolol in the dog heart in situ as assessed by automated devices.
Topics: Animals; Carteolol; Depression, Chemical; Dogs; Dose-Response Relationship, Drug; Female; Heart Conduction System; Male; Methods; Pindolol; Propanolamines; Propranolol | 1978 |
[Increased creatine phosphokinase (CPK) level and muscle symptoms during beta-blocker therapy].
Topics: Adrenergic beta-Antagonists; Aged; Carteolol; Creatine Kinase; Female; Humans; Hypertension; Male; Middle Aged; Muscles; Pindolol | 1986 |
Interactions of some partial agonists with high and low affinity binding sites in beta-adrenoceptors.
Topics: Adrenergic beta-Agonists; Animals; Binding Sites; Carteolol; Cecum; Guinea Pigs; In Vitro Techniques; Isoproterenol; Male; Pindolol; Propanolamines; Propranolol; Receptors, Adrenergic, beta | 1987 |
A trial for kinetic evaluation of the antagonistic potency of several beta-antagonists on presynaptic beta-adrenoceptors.
Topics: Adrenergic beta-Antagonists; Animals; Carteolol; Guinea Pigs; In Vitro Techniques; Isoproterenol; Kinetics; Male; Nadolol; Norepinephrine; Pindolol; Propranolol; Pulmonary Artery; Receptors, Adrenergic, beta | 1987 |
[Comparative multicenter study of carteolol eyedrops with other beta blockers in 768 patients under normal conditions].
Topics: Adrenergic beta-Antagonists; Carteolol; Drug Evaluation; Glaucoma; Humans; Intraocular Pressure; Metipranolol; Ophthalmic Solutions; Pindolol; Propanolamines; Time Factors; Timolol | 1988 |
[Effect of beta receptor blockader administration on the serum CPK level].
Topics: Adrenergic beta-Antagonists; Carteolol; Creatine Kinase; Humans; Pindolol; Propranolol | 1982 |
A study on the cardiodepressant action of a beta-blocking agent carteolol in heart-lung preparation of the dog.
Topics: Animals; Anti-Arrhythmia Agents; Blood Pressure; Cardiac Output; Carteolol; Dogs; Dose-Response Relationship, Drug; Female; Heart Rate; Hemodynamics; Isoproterenol; Male; Myocardial Contraction; Pindolol; Propanolamines; Propranolol | 1984 |
[Human pharmacology of carteolol].
Topics: Administration, Oral; Blood Platelets; Carteolol; Coronary Disease; Hemodynamics; Humans; Hypertension; Injections, Intravenous; Male; Pindolol; Propanolamines; Propranolol; Substance Withdrawal Syndrome | 1983 |
Effects of propranolol, pindolol and carteolol on acute regional myocardial ischemia in isolated rabbit hearts.
Topics: Adrenergic beta-Antagonists; Animals; Carteolol; Catecholamines; Coronary Circulation; Electric Stimulation; Heart; Heart Rate; In Vitro Techniques; Male; Myocardial Ischemia; Myocardium; NAD; Norepinephrine; Oxygen Consumption; Pindolol; Propranolol; Rabbits; Reserpine; Tyramine; Ventricular Function, Left | 1993 |
Functional properties of atypical beta-adrenoceptors on the guinea pig duodenum.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Alprenolol; Animals; Bupranolol; Carteolol; Clenbuterol; Dobutamine; Dopamine; Dose-Response Relationship, Drug; Duodenum; Epinephrine; Ethanolamines; Fenoterol; Guinea Pigs; In Vitro Techniques; Isoproterenol; Male; Muscle Relaxation; Nadolol; Norepinephrine; Phenylephrine; Pindolol; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Stereoisomerism | 2001 |